» Authors » Nandini A Sahasrabuddhe

Nandini A Sahasrabuddhe

Explore the profile of Nandini A Sahasrabuddhe including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 42
Citations 2010
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sahasrabuddhe N, Korlimarla A, Kulkarni M, Kusuma V, Prabhu J, Dixit S, et al.
Indian J Cancer . 2022 Jan; 58(4):598-602. PMID: 34975100
Triple-negative breast cancers (TNBC) are one of the most aggressive forms of breast cancers. With poor patient outcomes, it presents a great burden on the healthcare systems. There have been...
2.
Solanki H, Raja R, Zhavoronkov A, Ozerov I, Artemov A, Advani J, et al.
Oncoscience . 2021 Sep; 8:108-109. PMID: 34589558
[This corrects the article DOI: 10.18632/oncoscience.395.].
3.
Yelamanchi S, Tyagi A, Mohanty V, Dutta P, Korbonits M, Chavan S, et al.
OMICS . 2018 Dec; 22(12):759-769. PMID: 30571610
The pituitary function is regulated by a complex system involving the hypothalamus and biological networks within the pituitary. Although the hormones secreted from the pituitary have been well studied, comprehensive...
4.
Wu X, Zahari M, Renuse S, Sahasrabuddhe N, Chaerkady R, Kim M, et al.
Clin Proteomics . 2018 Nov; 15:37. PMID: 30479584
[This corrects the article DOI: 10.1186/s12014-018-9197-x.].
5.
Wu X, Zahari M, Renuse S, Sahasrabuddhe N, Chaerkady R, Kim M, et al.
Clin Proteomics . 2018 Jun; 15:21. PMID: 29946230
Background: Cancer-associated fibroblasts (CAFs) are one of the most important components of tumor stroma and play a key role in modulating tumor growth. However, a mechanistic understanding of how CAFs...
6.
Solanki H, Raja R, Zhavoronkov A, Ozerov I, Artemov A, Advani J, et al.
Oncoscience . 2018 Mar; 5(1-2):21-38. PMID: 29556515
EGFR-based targeted therapies have shown limited success in smokers. Identification of alternate signaling mechanism(s) leading to TKI resistance in smokers is critically important. We observed increased resistance to erlotinib in...
7.
Babu N, Advani J, Solanki H, Patel K, Jain A, Khan A, et al.
Microrna . 2018 Jan; 7(1):38-53. PMID: 29299995
Background: Dysregulation of miRNAs is associated with the development of non-small cell lung cancer (NSCLC). It is imperative to study the dysregulation of miRNAs by cigarette smoke which will affect...
8.
Solanki H, Advani J, Khan A, Radhakrishnan A, Sahasrabuddhe N, Pinto S, et al.
OMICS . 2017 Aug; 21(8):474-487. PMID: 28816646
Proteomics analysis of chronic cigarette smoke exposure is a rapidly emerging postgenomics research field. While smoking is a major cause of lung cancer, functional studies using proteomics approaches could enrich...
9.
Advani J, Subbannayya Y, Patel K, Khan A, Patil A, Jain A, et al.
OMICS . 2017 Jul; 21(7):390-403. PMID: 28692419
Chronic exposure to cigarette smoke markedly increases the risk for lung cancer. Regulation of gene expression at the post-transcriptional level by miRNAs influences a variety of cancer-related interactomes. Yet, relatively...
10.
Radhakrishnan A, Nanjappa V, Raja R, Sathe G, Puttamallesh V, Jain A, et al.
Sci Rep . 2017 Jun; 7:46864. PMID: 28650432
This corrects the article DOI: 10.1038/srep36132.